Assessments of immune cell infiltration to both tumor site and dLNs demonstrated significant increases of monocytes, NK cells and neutrophils within 14 h of treatment with a combination of CV8102 and anti-PD-1 antibodies. The gene discussed is PDCD1; the disease is neoplasm.